Skip to playerSkip to main content
  • 18 hours ago
How did Chief Medical Officer Dr. Roshan Parasram end up with the responsibility of granting Special Permission permits for the importation of pharmaceuticals?

It's a question which came up repeatedly at the Public Accounts Appropriations Committee. But none of the senior officials at the Health Ministry could answer.

The hearing revealed alleged improper practices, with an order being given for a search of the Ministry's computer servers.

Alicia Boucher has more in this report.
Transcript
00:00The Minister of Health is the only one responsible in law for the granting of special permission permits for the
00:05importation of drugs,
00:07whether it be narcotics on the schedule or pharmaceuticals.
00:10But the Public Accounts Appropriations Committee has learned that from 2015 to 2024, a different practice occurred.
00:17Who decides that, whether the permission is granted or not?
00:24For the special permit?
00:26Yes.
00:27Would be the CMO.
00:28Chief Medical Officer.
00:29Asked by PAAC Chairman Jack Dale Singh where in the Food and Drugs Act gives such power to CMO Dr.
00:36Roshan Parasram,
00:37former Director of the Chemistry, Food and Drugs Division, Faz Khan, makes this admission.
00:43For my knowledge, none exists.
00:45The CMO was not party to the hearing to provide an answer as to where such a decision came from.
00:52I want an answer.
01:00There are four senior, five senior officials in the Ministry of Health here.
01:06And not one of you can give me an answer as to where this power granted to the CMO was
01:17exercised.
01:20How much is the amount of money?
01:22How many dollars?
01:25Almost 3,000 times.
01:272,761 times to be exact from the years 2015 to 2024, based on documentation provided to the PAAC.
01:59So, we have 2,700 and more instances.
02:06There are instances where whoever it is acted unlawfully, illegally, without jurisdiction and ultra-virus, the powers contained in the
02:20act.
02:20Then, there's a policy outlining conditions for special permission.
02:25One, unavailability of drugs from the registered manufacturer.
02:29Two, the need for clinically therapeutic alternate drug due to the unavailability of the existing preparation.
02:36This may be due to supply chain disruptions for various reasons.
02:41And three, personal use.
02:43Health officials say this policy had no cabinet approval.
02:47Apart from that, questions as to how Listerine, Bengay-Ridoxan and other drugs that seemingly fell outside of the approval
02:55criteria ended up receiving approval are yet to be clarified.
02:59Who would have recommended that to the CMO to sign off on?
03:04Okay, so I do recall recommending Listerine and those things.
03:08Smith Robertson, which is a vendor, has been said to be a beneficiary of the majority of the permits by
03:13way of percentage.
03:14But that aside, a conflict of interest allegedly done under directive from Dr. Paris Ram.
03:20The CFDD, which is the statutory regulator for these importers, was in direct contact with Smith Robertson, requesting documentation and
03:29issuing advice on moving the approval process forward.
03:33It says this was done for all other importers.
03:37We want a comprehensive search of the silver.
03:41We want to see that there was equity and that all importers were given the same treatment as Smith Robertson.
03:48The CMO was not copied in emails between the CFDD and Smith Robertson pertaining to that and admitted error on
03:55the part of Doonat Cebu.
03:57Claire answers about why there were unnamed individuals importing under special permission for personal use to supply the government are
04:06also pending.
04:06The procedure used for the special permission permits has since been brought in and by the CMO, who had indicated
04:13that intention to the CFDD during some of the later approvals.
04:18The PAAC chairman says the CMO will be invited to respond to the claims.
04:22We have reached out to Dr. Paris Ram and are awaiting a response.
04:27TV6 News also contacted former Health Minister Terence D'Alsing.
04:30He tells us that he would have granted special permission permits on advice from the CMO in keeping with proper
04:37procedure.
04:38But he says he is unaware of any such permits that were allegedly granted by the CMO.
04:44Alicia Boucher, TV6 News.
Comments